If you or a loved one has been diagnosed with either Meningioma, Pseudotumor Cerebri OR Idiopathic Intracranial Hypertension (IIH) within 3 years of last injection after Depo-Provera treatment, you may be eligible to file a claim
Vaso-Occlusive Crises (VOCs): Oxbryta has been associated with an increased risk of VOCs, a painful and potentially life-threatening complication of sickle cell disease. VOCs happen when misshapen red blood cells block blood flow to tissues, leading to intense pain and possible organ damage. Patients using Oxbryta experienced more frequent VOCs compared to those not on the medication, increasing their risk of long-term health issues such as kidney failure and stroke.
Fatal Complications: Unfortunately, some patients taking Oxbryta faced fatal complications. Studies have shown a higher incidence of deaths among Oxbryta users compared to those on a placebo, raising serious concerns about Pfizer’s safety measures and its commitment to patient safety.
At Selinger Law, we are leading the charge in litigation against Pfizer, representing those harmed by the severe side effects of Oxbryta. We believe that Pfizer did not conduct sufficient testing or fully disclose the serious risks the drug posed to sickle cell patients. Our dedicated attorneys are committed to holding Pfizer accountable and securing the compensation our clients rightfully deserve.
We help you seek Justice & Compensation Due.